PROF vs SPGI · rev $10.7M vs P/E 27, rev $15.34B
Profound Medical Corp (PROF) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
PROF currently screens at market cap $238.7M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the PROF and SPGI stock pages for the full models.
Not investment advice.